JP7618641B2 - 新規アレルゲン - Google Patents

新規アレルゲン Download PDF

Info

Publication number
JP7618641B2
JP7618641B2 JP2022500515A JP2022500515A JP7618641B2 JP 7618641 B2 JP7618641 B2 JP 7618641B2 JP 2022500515 A JP2022500515 A JP 2022500515A JP 2022500515 A JP2022500515 A JP 2022500515A JP 7618641 B2 JP7618641 B2 JP 7618641B2
Authority
JP
Japan
Prior art keywords
protein
amino acid
variant
isolated
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022500515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538691A5 (https=
JPWO2021004885A5 (https=
JP2022538691A (ja
Inventor
ヨナス リドホルム
ラース マットソン
アンジェリカ エーレンベルク
ホーカン ラーソン
ヨナス エストリング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Phadia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia AB filed Critical Phadia AB
Publication of JP2022538691A publication Critical patent/JP2022538691A/ja
Publication of JP2022538691A5 publication Critical patent/JP2022538691A5/ja
Publication of JPWO2021004885A5 publication Critical patent/JPWO2021004885A5/ja
Application granted granted Critical
Publication of JP7618641B2 publication Critical patent/JP7618641B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2022500515A 2019-07-05 2020-07-02 新規アレルゲン Active JP7618641B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1950853-0 2019-07-05
SE1950853 2019-07-05
PCT/EP2020/068670 WO2021004885A1 (en) 2019-07-05 2020-07-02 Novel allergen

Publications (4)

Publication Number Publication Date
JP2022538691A JP2022538691A (ja) 2022-09-05
JP2022538691A5 JP2022538691A5 (https=) 2023-07-10
JPWO2021004885A5 JPWO2021004885A5 (https=) 2023-07-10
JP7618641B2 true JP7618641B2 (ja) 2025-01-21

Family

ID=71465346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500515A Active JP7618641B2 (ja) 2019-07-05 2020-07-02 新規アレルゲン

Country Status (4)

Country Link
US (1) US12539330B2 (https=)
EP (1) EP3994155A1 (https=)
JP (1) JP7618641B2 (https=)
WO (1) WO2021004885A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250276057A1 (en) * 2021-01-13 2025-09-04 Phadia Ab Novel allergen isoform variants
WO2023058337A1 (ja) * 2021-10-07 2023-04-13 大鵬薬品工業株式会社 新規ビャクシン花粉タンパク質

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001231580A (ja) 1999-12-17 2001-08-28 Meiji Milk Prod Co Ltd マウンテンシダー花粉アレルゲンタンパク質及び該タンパク質をコードする核酸分子
JP2006217896A (ja) 2005-02-14 2006-08-24 Japan Science & Technology Agency スギ花粉由来の新規アレルゲン
JP2013527846A (ja) 2010-04-30 2013-07-04 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
JP2017079742A (ja) 2016-11-16 2017-05-18 イミュノミック セラピューティックス， インコーポレイテッドＩｍｍｕｎｏｍｉｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． アレルギー治療のための核酸

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250276057A1 (en) * 2021-01-13 2025-09-04 Phadia Ab Novel allergen isoform variants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001231580A (ja) 1999-12-17 2001-08-28 Meiji Milk Prod Co Ltd マウンテンシダー花粉アレルゲンタンパク質及び該タンパク質をコードする核酸分子
JP2006217896A (ja) 2005-02-14 2006-08-24 Japan Science & Technology Agency スギ花粉由来の新規アレルゲン
JP2013527846A (ja) 2010-04-30 2013-07-04 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
JP2017079742A (ja) 2016-11-16 2017-05-18 イミュノミック セラピューティックス， インコーポレイテッドＩｍｍｕｎｏｍｉｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． アレルギー治療のための核酸

Also Published As

Publication number Publication date
WO2021004885A1 (en) 2021-01-14
EP3994155A1 (en) 2022-05-11
US20220241406A1 (en) 2022-08-04
US12539330B2 (en) 2026-02-03
JP2022538691A (ja) 2022-09-05

Similar Documents

Publication Publication Date Title
Heiss et al. Identification of a 60 kd cross-reactive allergen in pollen and plant-derived food
Asturias et al. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen‐specific immunotherapy
CA2673366C (en) Novel prostate kallikrein allergen
JP7618641B2 (ja) 新規アレルゲン
RS57626B1 (sr) Hipoalergen
US20250276057A1 (en) Novel allergen isoform variants
EP2027147A1 (en) Phl p 1 allergen derivative
AU2002242273B2 (en) Compositions of multimeric profilin for diagnosis and treatment of allergies
US9724407B2 (en) Horse allergen and methods
US9757447B2 (en) Recombinantly produced allergens
CA2460392A1 (en) Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity
US20050215766A1 (en) Allergen from mugwort pollen
US10753946B2 (en) Allergen

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240618

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250108

R150 Certificate of patent or registration of utility model

Ref document number: 7618641

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150